Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Pro-Pharmaceuticals Reports Second Quarter Results
August 31st, 2007
Pro-Pharmaceuticals, Inc. (Amex: PRW), a company "Advancing Drugs Through Glycoscience(R)", reported its second quarter and six months financial results, ended June 30, 2007. For the second quarter of 2007, the Company reported net income of $36,000, or $0.00 per share, basic and fully diluted, compared with net income of $230,000, or $0.01 per share basic or ($0.03) per share fully diluted, for the same period in 2006. Approximately $1,819,000 of the second quarter results were non-cash expenses relating to the change in fair value of the convertible debentures and warrant liabilities compared with $2,868,000 in the second quarter of 2006. For the...
Source: Drug Week (2007-08-31)
|
